Supernus Pharmaceuticals Statistics
Total Valuation
SUPN has a market cap or net worth of $1.66 billion. The enterprise value is $1.40 billion.
| Market Cap | 1.66B |
| Enterprise Value | 1.40B |
Important Dates
The next estimated earnings date is Tuesday, August 6, 2024, after market close.
| Earnings Date | Aug 6, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
SUPN has 54.97 million shares outstanding. The number of shares has decreased by -10.93% in one year.
| Shares Outstanding | 54.97M |
| Shares Change (YoY) | -10.93% |
| Shares Change (QoQ) | +0.59% |
| Owned by Insiders (%) | 5.02% |
| Owned by Institutions (%) | 106.67% |
| Float | 49.05M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 17.51 |
| PS Ratio | 2.78 |
| Forward PS | 2.69 |
| PB Ratio | 1.79 |
| P/FCF Ratio | 16.66 |
| PEG Ratio | 1.47 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 17.50, with an EV/FCF ratio of 14.00.
| EV / Earnings | n/a |
| EV / Sales | 2.34 |
| EV / EBITDA | 17.50 |
| EV / EBIT | n/a |
| EV / FCF | 14.00 |
Financial Position
The company has a current ratio of 1.73, with a Debt / Equity ratio of 0.04.
| Current Ratio | 1.73 |
| Quick Ratio | 1.42 |
| Debt / Equity | 0.04 |
| Debt / EBITDA | 0.41 |
| Debt / FCF | 0.33 |
| Interest Coverage | -5.60 |
Financial Efficiency
Return on equity (ROE) is -1.70% and return on invested capital (ROIC) is -1.68%.
| Return on Equity (ROE) | -1.70% |
| Return on Assets (ROA) | -1.20% |
| Return on Capital (ROIC) | -1.68% |
| Revenue Per Employee | $916,259 |
| Profits Per Employee | -$23,785 |
| Employee Count | 652 |
| Asset Turnover | 0.46 |
| Inventory Turnover | 0.92 |
Taxes
In the past 12 months, SUPN has paid $9.50 million in taxes.
| Income Tax | 9.50M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -0.23% in the last 52 weeks. The beta is 0.91, so SUPN's price volatility has been similar to the market average.
| Beta (5Y) | 0.91 |
| 52-Week Price Change | -0.23% |
| 50-Day Moving Average | 27.60 |
| 200-Day Moving Average | 28.37 |
| Relative Strength Index (RSI) | 74.92 |
| Average Volume (20 Days) | 679,995 |
Short Selling Information
The latest short interest is 6.12 million, so 11.14% of the outstanding shares have been sold short.
| Short Interest | 6.12M |
| Short Previous Month | 5.83M |
| Short % of Shares Out | 11.14% |
| Short % of Float | 12.48% |
| Short Ratio (days to cover) | 8.16 |
Income Statement
In the last 12 months, SUPN had revenue of $597.40 million and -$15.51 million in losses. Loss per share was -$0.29.
| Revenue | 597.40M |
| Gross Profit | 520.77M |
| Operating Income | -16.21M |
| Pretax Income | -6.01M |
| Net Income | -15.51M |
| EBITDA | 79.91M |
| EBIT | -5.10M |
| Loss Per Share | -$0.29 |
Balance Sheet
The company has $297.74 million in cash and $32.99 million in debt, giving a net cash position of $264.74 million or $4.82 per share.
| Cash & Cash Equivalents | 297.74M |
| Total Debt | 32.99M |
| Net Cash | 264.74M |
| Net Cash Per Share | $4.82 |
| Equity (Book Value) | 929.17M |
| Book Value Per Share | 16.90 |
| Working Capital | 229.77M |
Cash Flow
In the last 12 months, operating cash flow was $100.36 million and capital expenditures -$521,000, giving a free cash flow of $99.84 million.
| Operating Cash Flow | 100.36M |
| Capital Expenditures | -521,000 |
| Free Cash Flow | 99.84M |
| FCF Per Share | $1.82 |
Margins
Gross margin is 87.17%, with operating and profit margins of -2.71% and -2.60%.
| Gross Margin | 87.17% |
| Operating Margin | -2.71% |
| Pretax Margin | -1.01% |
| Profit Margin | -2.60% |
| EBITDA Margin | 13.38% |
| EBIT Margin | -0.85% |
| FCF Margin | 16.71% |
Dividends & Yields
SUPN does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 10.93% |
| Shareholder Yield | 10.93% |
| Earnings Yield | -0.93% |
| FCF Yield | 6.00% |
Analyst Forecast
The average price target for SUPN is $41.00, which is 35.54% higher than the current price. The consensus rating is "Buy".
| Price Target | $41.00 |
| Price Target Difference | 35.54% |
| Analyst Consensus | Buy |
| Analyst Count | 1 |
| Revenue Growth Forecast (5Y) | 7.01% |
| EPS Growth Forecast (5Y) | 200.44% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
SUPN has an Altman Z-Score of 3.84 and a Piotroski F-Score of 6.
| Altman Z-Score | 3.84 |
| Piotroski F-Score | 6 |